Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Gilead Sciences (NQ: GILD )

62.25 USD UNCHANGED
Official Closing Price Updated: 7:58 PM EDT, Sep 25, 2020 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 7,142,800
Open 62.10
Bid (Size) 62.09 (1)
Ask (Size) 62.24 (3)
Prev. Close 62.25
Today's Range 61.77 - 62.51
52wk Range 60.89 - 85.97
Shares Outstanding 1,300,260,832
Dividend Yield 3.58%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
EUROPEAN COMMISSION GRANTS MARKETING AUTHORIZATION FOR JYSELECA® (FILGOTINIB) FOR THE TREATMENT OF ADULTS WITH MODERATE TO SEVERE ACTIVE RHEUMATHOID ARTHRITIS
From GlobeNewswire News Releases
European Commission Grants Marketing Authorization for Jyseleca® ▼ (Filgotinib) for the Treatment of Adults With Moderate to Severe Active Rheumatoid Arthritis
Gilead Sciences, Inc. (Nasdaq: GILD) and Galapagos NV (Euronext & Nasdaq: GLPG) today announced that the European Commission (EC) has granted marketing authorization for Jyseleca® (filgotinib 200 mg... 
From Business Wire News Releases

Performance

YTD
-4.57%
-4.57%
1 Month
-5.11%
-5.11%
3 Month
-16.52%
-16.52%
6 Month
-14.55%
-14.55%
1 Year
-1.66%
-1.66%

More News

Read More
Jyseleca® (filgotinib) approved in Japan for rheumatoid arthritis
From GlobeNewswire News Releases
Jyseleca® (Filgotinib) Approved in Japan for Rheumatoid Arthritis
From Business Wire News Releases
Gilead Sciences Prices $7.25 Billion of Senior Unsecured Notes
From Business Wire News Releases
Investors Are Scrambling To Get Ahead Of The Oncology Drug Market Boom; 1 Company Could Revolutionize The Industry
From Penny Stocks to Buy, Picks, News and Information | PennyStocks.com - Feed
Nanomedicine Seen As A Promising Approach For Diagnosis and Treatment Against COVID
Tags Featured News
From FinancialNewsMedia.com Newswire for Stock Alerts, Public Company News Alert
Nanomedicine Seen As A Promising Approach For Diagnosis and Treatment Against COVID
From PR Newswire
Gilead Settles US Kickback Allegations For $97M
Tags Biotech UTHR JNJ
From Benzinga
Better Coronavirus Stock: Gilead Sciences vs. Moderna
Tags Market News MRNA GILD
From Motley Fool
Initial data from a pair of clinical trials may revive interest in arthritis drugs as COVID-19 treatments
Tags SPX General GILD
From MarketWatch
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.